150 completed. 150 Phase 2, 18 Phase 3, 9 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 150 | Completed 150 |
| Phase 3 | 18 | Completed 18 |
| Phase 1 | 9 | Completed 9 |
Follow Mycoses: new trials by email Literature Review of Mycoses trials Research Report on Mycoses
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| iMagIng pulmonaRy Aspergillosis Using Gallium-68-dEferoxamine Radiopharmaceutical: gallium-68-deferoxamine ([68Ga]Ga-DFO-B) - Pulmonary Aspergillosis, Chronic Pulmonary Aspergillosis | Phase 2 | Completed | Radboud University Medical Center | 10 | 2025-05-01 | 2026-08-18 |
| Postbiotic as Adjunct Treatment for Vaginal Candidiasis Postbiotic, Placebo - Vaginal Candidiasis | Phase 2 / Phase 3 | Completed | Min-Tze LIONG | 99 | 2024-06-02 | 2026-07-07 |
| Optimizing the Dose of Flucytosine for the Treatment of Cryptococcal Meningitis AMBITION trial control, Flucytosine - Cryptococcal Meningitis | Phase 2 | Completed | University of Minnesota | 48 | 2024-04-09 | 2025-08-27 |
| Pilot Study of Swift Microwave Device for Onychomycosis Swift Microwave treatment - weekly x 4wks, Swift Microwave treatment - Every other week x 4wks, Swift Microwave treatment - Every other week x 24wks - Onychomycosis of Toenail | Phase 1 / Phase 2 | Completed | Mediprobe Research Inc. | 39 | 2023-03-27 | 2024-11-18 |
| Amphotericin Versus Posaconazole for Pulmonary Mucormycosis Posaconazole 600 mg followed by posaconazole 300 mg once daily, Liposomal Amphotericin B - Mucormycosis; Pulmonary (Etiology) | Phase 2 | Completed | Post Graduate Institute of Medical Education and Research, Chandigarh | 82 | 2022-07-01 | 2026-05-22 |
| Safety and Efficacy of Interferon-Gamma 1b in Patients With Candidemia Interferon Gamma-1B - Candidemia | Phase 2 | Completed | Radboud University Medical Center | 65 | 2022-03-31 | 2026-06-22 |
| An Open-label Safety Study of PC945 (Opelconazole) Prophylaxis or Pre-emptive Therapy Against Pulmonary Aspergillosis in Lung Transplant Recipients (OPERA-S Study) Opelconazole, Standard of Care - Pulmonary Aspergillosis | Phase 2 | Completed | Pulmocide Ltd | 102 | 2021-11-19 | 2026-04-30 |
| World Health Organization (WHO) , COVID19 Case Series of Post Covid 19 Rhino Orbito Cerebral Mucormycosis in Egypt debridment - Mucormycosis; Rhinocerebral (Etiology), COVID-19 | Phase 1 / Phase 2 | Completed | Nasser Institute For Research and Treatment | 35 | 2021-05-23 | 2024-02-20 |
| A Trial Involving Treatment of BB2603 in Subjects With Distal Subungual Onychomycosis of the Toenail BB2603-1, BB2603-3, BB2603-10 - Distal Subungual Onychomycosis, Fungal Infection | Phase 2 | Completed | Blueberry Therapeutics | 111 | 2021-03-22 | 2023-08-01 |
| A Trial to Evaluate the Safety and Antimicrobial Efficacy of DBI-002 Probiotic in Adults With Tinea Versicolor DBI-002 probiotic gel, Aqueous gel - Tinea Versicolor | Phase 2 | Completed | DermBiont, Inc. | 34 | 2021-03-16 | 2025-07-03 |
| Investigating Treatment With Dupilumab in Patients With Allergic Bronchopulmonary Aspergillosis (ABPA) (LIBERTY ABPA AIRED) dupilumab, Placebo - Allergic Bronchopulmonary Aspergillosis | Phase 2 | Completed | Regeneron Pharmaceuticals | 62 | 2020-09-15 | 2025-04-04 |
| Efficacy and Safety Study of Miconazole Oil Versus Vehicle on Fungal Infection of the Ear Canal (Otomycosis) miconazole 2% oil, vehicle oil - Otomycosis | Phase 2 / Phase 3 | Completed | Hill Dermaceuticals, Inc. | 382 | 2020-07-08 | 2024-01-19 |
| Randomized Trial of Liposomal Amphotericin B for Histoplasmosis in AIDS Patients single dose of L-AmB, 2 doses of L-AmB, 2 weeks of L-AmB - Histoplasmosis, AIDS | Phase 2 | Completed | Alessandro Pasqualotto | 118 | 2020-02-14 | 2025-03-14 |
| An Open-label Study of APX001 for Treatment of Patients With Candidemia/Invasive Candidiasis Caused by Candida Auris APX001 - Candidemia, Invasive Candidiases | Phase 2 | Completed | Basilea Pharmaceutica | 9 | 2019-12-13 | 2025-09-16 |
| Encochleated Oral Amphotericin for Cryptococcal Meningitis Trial (EnACT) MAT2203, Amphotericin B - Cryptococcal Meningitis | Phase 1 / Phase 2 | Completed | Matinas BioPharma Nanotechnologies, Inc. | 178 | 2019-10-24 | 2023-03-31 |
| A Comparison Study of UHE-103 Cream in Subjects With Moccasin Type Tinea Pedis UHE-103A1 cream, UHE-103A2 cream, UHE-103B cream - Tinea Pedis | Phase 2 | Completed | Therapeutics, Inc. | 240 | 2019-03-15 | 2021-10-28 |
| A Trial to Evaluate the Safety and and Tolerability of DBI-001 in Patients With Tinea Pedis Janthinobacterium lividum - Tinea Pedis | Phase 2 | Completed | DermBiont, Inc. | 12 | 2019-02-19 | 2025-06-17 |
| An Efficacy and Safety Study of APX001 in Non-Neutropenic Patients With Candidemia APX001 - Candidemia | Phase 2 | Completed | Basilea Pharmaceutica | 21 | 2018-10-03 | 2025-09-16 |
| Endemic Mycoses Treatment With SUBA-itraconazole vs Itraconazole SUBA itraconazole, Conventional itraconazole - Invasive Fungal Infections | Phase 2 / Phase 3 | Completed | University of Alabama at Birmingham | 88 | 2018-09-17 | 2023-07-07 |
| Empiric Therapy of Patients With Persistent Fever and Agranulocytosis Using Caspofungin Caspofungin - Fungal Infection | Phase 2 | Completed | Cttq | 32 | 2018-09-17 | 2021-07-07 |
Showing 20 of 150. Sign in to see all of them.
Onychomycosis (30) · Candidiasis (17) · Aspergillosis (15) · Candidiasis, Vulvovaginal (14) · Tinea Pedis (13) · HIV Infections (11) · Aspergillosis, Allergic Bronchopulmonary (9) · Acquired Immunodeficiency Syndrome (8) · Candidemia (8) · Meningitis, Cryptococcal (7) · Candidiasis, Invasive (6) · Invasive Fungal Infections (6) · AIDS-Related Opportunistic Infections (5) · Candidiasis, Oral (5)
Bacterial Infections and Mycoses (150) · Infections (149) · Skin Diseases, Infectious (55) · Skin and Connective Tissue Diseases (55) · Dermatomycoses (54) · Skin Diseases (54) · Tinea (43) · Nail Diseases (30) · Immune System Diseases (28) · Pathological Conditions, Signs and Symptoms (28) · Genital Diseases (27) · Urogenital Diseases (27) · Lung Diseases (22) · Respiratory Tract Diseases (22)
Fluconazole (17) · Caspofungin (13) · Itraconazole (11) · Amphotericin B (9) · liposomal amphotericin B (8) · Micafungin (7) · Voriconazole (6) · posaconazole (6) · Terbinafine (5) · tavaborole (5) · Glucocorticoids (4) · Miconazole (4) · VT-1161 (4) · Anidulafungin (3) · Atovaquone (3)
Pfizer (13) · National Institute of Allergy and Infectious Diseases (NIAID) (12) · Merck Sharp & Dohme LLC (9) · Post Graduate Institute of Medical Education and Research, Chandigarh (7) · Nitric BioTherapeutics, Inc (4) · Viamet (4) · Astellas Pharma Inc (3) · Matinas BioPharma Nanotechnologies, Inc. (3) · Scynexis, Inc. (3) · Almirall, S.A. (2) · Basilea Pharmaceutica (2) · Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) (2) · DermBiont, Inc. (2) · Hill Dermaceuticals, Inc. (2) · Kerman University of Medical Sciences (2)
United States (66) · Germany (18) · France (13) · Canada (12) · India (11) · Spain (10) · Italy (9) · Belgium (8) · Netherlands (7) · United Kingdom (7) · Egypt (5) · Israel (5) · Mexico (5) · Poland (5) · Puerto Rico (5)
David Angulo, MD (3) · William Dismukes (3) · Christoph Willers, MD, MBA (2) · Kenneth Hodge, MD (2) · Marc Engelhardt (2) · Quyen T Nguyen, MD (2) · Ritesh Agarwal, MD, DM (2) · Sara R Botros, bachelor of clinical pharmacy (2) · A Vulto, PhD (1) · Aditya Gupta, MD,PhD (1) · Ahmed Fahal, Prof (1) · Alena Jandourek, MD (1)
PMID 36396498, PMID 16436724, PMID 16505648, PMID 16678903, PMID 18983417, PMID 19172247, PMID 19441980, PMID 19897055, PMID 20547942, PMID 20697067, PMID 21729932, PMID 21911573, PMID 21937481, PMID 21967490, PMID 22045986, PMID 23335740, PMID 23377392, PMID 24307695, PMID 25451051, PMID 25701307, PMID 26270686, PMID 26316385, PMID 26585431, PMID 29304768, PMID 29331473, PMID 29534874, PMID 29697768, PMID 29744900, PMID 30049743, PMID 30184181, PMID 30526582, PMID 30561849, PMID 30801037, PMID 32421854, PMID 32457106, PMID 32747357, PMID 32818963, PMID 32914187, PMID 32941647, PMID 32955088, PMID 33027187, PMID 33558294, PMID 33680981, PMID 34555149, PMID 34581270, PMID 34764182, PMID 35699443, PMID 35822920, PMID 36780493, PMID 36836250
2009 (4), 2008 (2), 2014 (1), 2015 (1), 2017 (1), 2019 (1), 2023 (1)